Pollen grains for oral vaccination

被引:87
作者
Atwe, Shashwati U. [1 ]
Ma, Yunzhe [1 ]
Gill, Harvinder Singh [1 ]
机构
[1] Texas Tech Univ, Dept Chem Engn, Lubbock, TX 79409 USA
基金
美国国家卫生研究院;
关键词
Lycopodium spores; Mucosal vaccination; Oral vaccination; Pollen shells; Sporopollenin; CHOLERA-TOXIN; GRASS-POLLEN; DELIVERY SYSTEMS; MUCOSAL VACCINE; HEPATITIS-B; RESPONSES; ADJUVANT; MICE; MICROPARTICLES; IMMUNOTHERAPY;
D O I
10.1016/j.jconrel.2014.08.010
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Oral vaccination can offer a painless and convenient method of vaccination. Furthermore, in addition to systemic immunity it has potential to stimulate mucosal immunity through antigen-processing by the gut-associated lymphoid tissues. In this study we propose the concept that pollen grains can be engineered for use as a simple modular system for oral vaccination. We demonstrate feasibility of this concept by using spores of Lycopodium clavatum (clubmoss) (LSs). We show that LSs can be chemically cleaned to remove native proteins to create intact clean hollow LS shells. Empty pollen shells were successfully filled with molecules of different sizes demonstrating their potential to be broadly applicable as a vaccination system. Using ovalbumin (OVA) as a model antigen, LSs formulated with OVA were orally fed to mice. LSs stimulated significantly higher anti-OVA serum IgG and fecal IgA antibodies compared to those induced by use of cholera toxin as a positive-control adjuvant. The antibody response was not affected by pre-neutralization of the stomach acid, and persisted for up to 7 months. Confocal microscopy revealed that LSs can translocate into mouse intestinal wall. Overall, this study lays the foundation of using LSs as a novel approach for oral vaccination. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 48 条
[11]   Mucosal delivery of vaccine antigens and its advantages in pediatrics [J].
De Magistnis, MT .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (01) :52-67
[12]  
Hesse M., 2009, POLLEN TERMINOLOGY
[13]   Mucosal immunity and vaccines [J].
Holmgren, J ;
Czerkinsky, C .
NATURE MEDICINE, 2005, 11 (04) :S45-S53
[14]  
Holmgren Jan, 2003, Expert Rev Vaccines, V2, P205, DOI 10.1586/14760584.2.2.205
[15]   The exodermis: a variable apoplastic barrier [J].
Hose, E ;
Clarkson, DT ;
Steudle, E ;
Schreiber, L ;
Hartung, W .
JOURNAL OF EXPERIMENTAL BOTANY, 2001, 52 (365) :2245-2264
[16]   Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates [J].
Hutin, YJF ;
Hauri, AM ;
Armstrong, GL .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7423) :1075-+
[17]   PERSORPTION OF POLLEN AND SPORES BY MEANS OF INTACT INTESTINAL-MUCOSA [J].
JORDE, W ;
LINSKENS, HF .
ACTA ALLERGOLOGICA, 1974, 29 (03) :165-175
[18]  
Kersten Gideon, 2004, Expert Rev Vaccines, V3, P453, DOI 10.1586/14760584.3.4.453
[19]   Immunological mechanisms of allergen-specific immunotherapy [J].
Larche, Mark ;
Akdis, Cezmi A. ;
Valenta, Rudolf .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (10) :761-771
[20]   Improvement of the systemic prime/oral boost strategy for systemic and local responses [J].
Lauterslager, TGM ;
Stok, W ;
Hilgers, LA .
VACCINE, 2003, 21 (13-14) :1391-1399